Press Releases April 23, 2026 07:00 AM

Aeluma to Participate in SPIE Defense + Security Conference

Aeluma to showcase scalable semiconductor technologies at 2026 SPIE Defense + Security Conference

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
ALMU

Aeluma, Inc., a US-based semiconductor company focusing on high-performance scalable technologies, announced its participation in the 2026 SPIE Defense + Security Conference. The company will exhibit its disruptive photonic and electronic semiconductor products, highlighting innovations in shortwave infrared sensors and quantum dot lasers. The event positions Aeluma to increase visibility within defense, aerospace, and AI-related markets amid ongoing industry supply challenges.

Aeluma to Participate in SPIE Defense + Security Conference
ALMU
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Aeluma will showcase its scalable semiconductor technologies including shortwave infrared image sensors and quantum dot lasers at the SPIE Defense + Security Conference.
  • The company's large-diameter wafer platform supports growing markets such as AI, mobile, defense, aerospace, quantum, and automotive sectors.
  • Aeluma emphasizes potential to scale high-performance semiconductor production amid supply chain challenges, highlighting its proprietary combined compound semiconductor platform.

GOLETA, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, announced today that it will participate in the 2026 SPIE Defense + Security Conference, the premier defense conference focused on sensing technologies rapidly being acquired and deployed across public, security, and government applications. The Conference will be held April 28-30 in National Harbor, Maryland.

Aeluma will exhibit at Booth #509 at the Gaylord National Resort & Convention Center to showcase its disruptive semiconductor technologies including scalable shortwave infrared image sensors, high-speed photodiodes, quantum dot lasers, and large-wafer heterogeneous integration.

Aeluma’s large-diameter wafer platform was engineered to facilitate scaling of photonics for growing markets including AI datacom, mobile and consumer electronics, defense and aerospace, and quantum. Demand for high-performance semiconductors is increasing while the industry faces supply chain challenges. Aeluma’s technology has the potential to scale without sacrificing performance. The SPIE Defense + Security Conference provides premier opportunities to highlight Aeluma’s innovations for the broader industry.

To meet with the Aeluma team at the event, attendees are encouraged to contact the company at [email protected].

About Aeluma

Aeluma (NASDAQ: ALMU) is a transformative semiconductor company specializing in high-performance photonic and electronic technologies that scale. The company’s proprietary platform combines compound semiconductors with scalable manufacturing used for mass market microelectronics to enable volume production and large-scale integration. Applications for Aeluma’s technology include mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum. Headquartered in Goleta, California, Aeluma operates state-of-the-art R&D and manufacturing capabilities for semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, test and validation. Aeluma also partners with production-scale fabrication foundries, packaging, and integration companies. For more information, visit www.aeluma.com.

Company:
Aeluma, Inc.
(805) 351-2707
[email protected]

Investor Contact:
Financial Profiles, Inc.
Alex Villalta
(310) 622-8227
[email protected]


Risks

  • Industry-wide semiconductor supply chain constraints could impact Aeluma's production and delivery timelines.
  • The competitive and rapidly evolving semiconductor industry technologies pose commercialization and adoption risks.
  • Dependence on partnerships with foundries for mass production introduces operational and supply uncertainties.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026